TWiV 932: Clinical update with Dr. Daniel Griffin
Episode 932 of the This Week in Virology podcast, hosted by Vincent Racaniello, titled "TWiV 932: Clinical update with Dr. Daniel Griffin" was published on September 3, 2022 and runs 49 minutes.
September 3, 2022 ·49m · This Week in Virology
Episode Description
In his weekly clinical update Dr. Griffin discusses vaccine effectiveness against influenza illness in children, clinical manifestations of infection with poliovirus, spike protein-independent attenuation of SARS-CoV-2 Omicron variant in laboratory mice, concordance of SARS-CoV-2 results in self-collected nasal swabs vs swabs collected by health care workers in children and adolescents, probable animal-to-human transmission of SARS-CoV-2 causing a pet shop-related outbreak, laboratory-confirmed COVID-19–associated hospitalizations among adults during BA.2 variant, SARS-CoV-2 specific T-cells and antibodies, Nirmatrelvir use and outcomes during the Omicron surge, real-world effectiveness of early Molnupiravir or Nirmatrelvir–ritonavir in hospitalized patients, and distinguishing features of long COVID.
Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode
- Vaccine effectiveness against Influenza illness in children (CID)
- Clinical manifestations of infection with Polio (JAMA)
- Characteristics of deaths among fully vaccinated persons with Coronavirus (CID)
- Spike protein attenuation of Omicron Variant in lab mice (Cell Reports)
- Concordance of SARS-CoV-2 results in nasal swabs self-collected vs healthcare collected (JAMA)
- Probable animal-to-human transmission of Sars-Cov-2 (CID)
- PAXLOVID patient eligibility screening checklist (FDA)
- Remdesivir fact sheet for providers (Veklury)
- Bebtelovimab fact sheet for providers (FDA)
- COVID-19–associated hospitalizations among adults during BA.2 variant (CDC)
- Sars-Cov-2 specific T-cells and antibodies (CID)
- Nirmatrelvir use and outcomes during the Omicron surge (NEJM)
- Effectiveness of early Molnupiravir or Nirmatrelvir–Ritonavir in hospitalized patients (The Lancet)
- Distinguishing features of long COVID (medRxiv)
- Unexplained post-acute infection syndromes (Nature Med)
- Contribute to Floating Doctors fundraiser at PWB
- Dr. Griffin's treatment guide (pdf)
- Letters read on TWiV 932
- Timestamps by Jolene. Thanks!
Intro music is by Ronald Jenkees
Send your questions for Dr. Griffin to [email protected]